Allianz Asset Management »

Janux Therapeutics shares owned by Allianz Asset Management

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Allianz Asset Management from 13F filings

Historical chart of Allianz Asset Management investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Allianz Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Allianz Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $398k 9.5k 41.89

More positions owned by Allianz Asset Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
UnitedHealth (UNH)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. Call Option (JPM)
Adobe Systems Incorporated (ADBE)
Vici Pptys (VICI)
Applied Materials (AMAT)
Ishares Tr Msci Emg Mkt Etf (EEM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Eli Lilly & Co. (LLY)

View all positions for Allianz Asset Management

Top funds holding Janux Therapeutics

RA Capital Management
BlackRock
Paradigm Biocapital Advisors
BlackRock
Henderson Group
Woodline Partners
Vanguard Group
EcoR1 Capital
State Street Corporation
OrbiMed Advisors
Citadel Advisors
Cormorant Asset Management
Logos Global Management
Lord, Abbett & Co
Geode Capital Management

View all funds holding Janux Therapeutics